MoonBase Explorer vs Tackling Type 2 in COPD

Discover the architecture of a polar station in a realistic lunar environment, with its cylindrical habitat modules, hydroponic greenhouses, radiation shields, walkways and passages protected from solar radiations, lunar landing area, photovoltaic panels rising over 100 m above the ground to provide permanent solar energy... Explore freely the Moon Base in a lunar environment of almost one square kilometer, interact with resident astronauts and teleport directly to 6 sites near the station or in the surrounding craters and valleys.

Chronic obstructive pulmonary disease (COPD) is a debilitating condition that is a leading global cause of hospitalization and mortality. Type 2 inflammation is a key driver of the etiopathogenesis of COPD and involves several effector immune cells, proteins, and pathways that result in life altering symptoms such as chest tightness, fatigue, chronic coughing, wheezing, difficulty breathing, and increased mucous production that can significantly impact the ability to do daily activities. Biologic therapies that target type 2 inflammation have emerged as a clinically relevant and effective treatment option to improve symptoms, lung function, and quality of life, and reduce the occurrences of exacerbations and associated hospitalizations. Explore this exciting program that depicts the role of biologic therapies in the management of COPD and strategies for providing patient-specific, guideline driven care to optimize outcomes.